Annual Operating Expenses
$2.16 M
+$1.93 M+853.45%
December 1, 2023
Summary
- As of February 7, 2025, LIPO annual total operating expenses is $2.16 million, with the most recent change of +$1.93 million (+853.45%) on December 1, 2023.
- During the last 3 years, LIPO annual operating expenses has risen by +$2.11 million (+4962.68%).
- LIPO annual operating expenses is now at all-time high.
Performance
LIPO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$412.70 K
+$122.10 K+42.02%
September 1, 2024
Summary
- As of February 7, 2025, LIPO quarterly total operating expenses is $412.70 thousand, with the most recent change of +$122.10 thousand (+42.02%) on September 1, 2024.
- Over the past year, LIPO quarterly operating expenses has increased by +$122.10 thousand (+42.02%).
- LIPO quarterly operating expenses is now -43.08% below its all-time high of $725.00 thousand, reached on December 1, 2023.
Performance
LIPO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LIPO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +853.5% | +42.0% |
| 3 y3 years | +4962.7% | +42.0% |
| 5 y5 years | +4962.7% | +42.0% |
LIPO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +853.5% | -43.1% | +972.0% |
| 5 y | 5-year | at high | +4962.7% | -43.1% | +972.0% |
| alltime | all time | at high | +4962.7% | -43.1% | +972.0% |
Lipella Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $412.70 K(+42.0%) |
| Jun 2024 | - | $290.60 K(-22.5%) |
| Mar 2024 | - | $375.00 K(-48.3%) |
| Dec 2023 | $2.16 M(+853.4%) | $725.00 K(+38.5%) |
| Sep 2023 | - | $523.50 K(+1.1%) |
| Jun 2023 | - | $517.60 K(+32.5%) |
| Mar 2023 | - | $390.70 K(+498.3%) |
| Dec 2022 | $226.20 K | $65.30 K(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $61.70 K(+60.3%) |
| Jun 2022 | - | $38.50 K(-59.0%) |
| Mar 2022 | - | $93.90 K(+1.4%) |
| Dec 2021 | $718.40 K(+1586.4%) | - |
| Dec 2021 | - | $92.60 K(+102.2%) |
| Sep 2021 | - | $45.80 K(-67.5%) |
| Jun 2021 | - | $140.90 K(-67.9%) |
| Mar 2021 | - | $439.10 K |
| Dec 2020 | $42.60 K | - |
FAQ
- What is Lipella Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals annual operating expenses year-on-year change?
- What is Lipella Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals quarterly operating expenses year-on-year change?
What is Lipella Pharmaceuticals annual total operating expenses?
The current annual operating expenses of LIPO is $2.16 M
What is the all time high annual operating expenses for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high annual total operating expenses is $2.16 M
What is Lipella Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, LIPO annual total operating expenses has changed by +$1.93 M (+853.45%)
What is Lipella Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of LIPO is $412.70 K
What is the all time high quarterly operating expenses for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high quarterly total operating expenses is $725.00 K
What is Lipella Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, LIPO quarterly total operating expenses has changed by +$122.10 K (+42.02%)